Get started
Vaxart, Inc. - Common StockVaxart, Inc. - Common StockVaxart, Inc. - Common Stock

Vaxart, Inc. - Common Stock

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

VXRT trade ideas

VXRT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE $VXRT - Vaxart, Inc. - Common Stock Initial Alert Price: $6.8 Price High: $12.74 % Gains/Losses: 87.35% (+66.85% More Than Expected) Potential Stop Loss: $12.103 VXRT is currently down 58.85% in today's trading session after reporting that neutralizing antibodies were not detected in volunteers after a single dose of its experimental oral COVID-19 vaccine candidate, VXA-CoV2-1, in a Phase 1 trial of 35 healthy adults. Researchers believe the antibodies play an important role in defending cells against the virus. This was the worse plunge for the stock since November 2012 and fortunately we updated everyone yesterday with concerns of consolidation and pullbacks but not to this extent. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:VXRTLong
by MyMIWallet
VXRT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE $VXRT - Vaxart, Inc. - Common Stock Initial Alert Price: $6.8 Price High: $24.9 % Gains/Losses: 266.18% (+245.85% More Than Expected) Potential Stop Loss: $23.655 Wanted to give an update on VXRT after the stock provided us with a 266.18% Gain on our initial trade alert on Jan. 14th and up another 100% from yesterday's trade alert update. Yesterday we were looking to see if the stock could breakthrough the $17.49 Levels of Resistance, so now we're to see if that will be come our future support or will it breakthrough those levels from a heavier sell-off from profit-taking and simple consolidation. Definitely something to keep an eye on going into tomorrow as the stock is still showing movement to the upside although we could see a potential gap down in tomorrow's pre-market session or market open. We would suggest watching how the stock opens tomorrow to determine our further outlook on the trade. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:VXRTLong
by MyMIWallet
3
VXRT Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE $VXRT - Vaxart, Inc. - Common Stock Initial Alert Price: $6.8 Price High: $15.8 % Gains/Losses: 132.35% (+111.85% More Than Expected) Potential Stop Loss: $15.01 VXRT hit $15.80 at it's high in today's trading session on pure moment as there has not been any press releases disclosing any news to explain the price action. This is our 2nd 100%+ Gainer of the Day, providing a 120% return on our initial trade alert from Jan. 14th, 2021. The stock found strong resistance at those $15.80 Price Levels and is currently show signs of consolidation, if not a pullback although, so we suggest preparing for profit taking here moving to protect your own profits. New Term: Split and Run Moving forward, when we refer to a Split and Run, we are referring to selling half of positions to lock in profits by protecting the initial investment into a stock while allowing the profits to continue to accumulate more profits on its own. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:VXRTLong
by MyMIWallet
Corona(Covid 19 vaccine) stock that can explode in 2021A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed? over the past year, Vaxart stock has soared over 1,250% because of its spot in the lucrative coronavirus vaccine race. Its stock performance even outpaced those of biotechs that have already brought their coronavirus vaccines to market, such as Moderna and BioNTech. In fact, over 30% of Vaxart stock has been sold short. Vaxart claims to have created an experimental coronavirus vaccine in the form of an oral tablet. One could potentially self-administer the vaccine pill, which is stable at room temperature. This would allow patients to order the vaccine online and have it delivered for at-home use. At the moment, Vaxart's experimental coronavirus vaccine is only in phase 1 clinical trials, with a new data readout expected by next week. Unfortunately, it's impossible to conclude how the experimental vaccine will work on humans from animal models. Hence, the candidate's phase 1 data release will likely be a make-or-break moment for Vaxart. Vaxart is under investigation by both the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) for insider trading and inaccurate statements regarding its role in Operation Warp Speed (OWS). Even though Vaxart has more than $133 million in cash and equivalents with no debt whatsoever, that's not nearly enough to move forward. Right now, it could cost billions of dollars to run a potential coronavirus vaccine through clinical trials involving tens of thousands of participants. The company will likely sell more stock to pay for its research and development (R&D) expenses or apply for grant funding -- just to stay afloat. Vaxart is far riskier than the other coronavirus vaccine drugmakers out there. Its corporate conduct is under federal investigation, and its vaccine candidate is in far too early a stage to draw any definitive conclusions about. With a market cap just south of $1 billion, it will undoubtedly become a very undervalued stock if it can bring a coronavirus vaccine to market. Moderna, which has done so, projects $11.7 billion in revenue from its mRNA-1273 vaccine alone. However, the probability of Vaxart achieving anything remotely similar is up for debate. Short-sellers and passionate bulls will be arguing over the stock for the next year. If you believe in Vaxart's science and have the stomach for a roller-coaster ride, then go for it.
NASDAQ:VXRT
by AlenCiken
ORAL PILL VACCINE !!! COVID 19-01/28/2021--------- BULL FLAG ON DAILY 01-29-2021-------BULL FLAG ON HOURLY FEBRUARY 3RD PRESENTATION ON CONFERENCE WITH DR. FAUCI AND OTHER LEGENDS ORAL VACCINE ------ COVID 19 PILL VACCINE ----- NOROVIRUS ----- FLU---- JNJ COLLABORATION---- NEXT WEEK IF FOLLOWED THE TREND AND NEWS are POSITIVE --- $16 IS EASY !!! IF FALL DOWN --- WILL GO TO $10.45 AND STAY THERE TILL ANOTHER DIRECTION! POSSIBLE SHORT SQUEEZE IF IT HITS $16, 33.97 MILLION SHORT AVAILABLE.. ONE OF THE MOST SHORTED TICKER IN 2020.
NASDAQ:VXRTLong
by Hope_Best
4
Inverse Head and ShouldersEarnings Estimated on 12-11 BMO.. Possible stop Inverse Head and shoulders patterns are reliable as a rule.. Head is at 3.50.. LS is 4.5.. RS is 5.28.. Some prefer the RS to be higher than the LS as they say a better outcome is acheived This is not to long entry level and the neckline is resistance until price is above it, then the neckline becomes support.. Not a recommendation.. Inverse H&S pattern completes when the asset's price rallies above the pattern's neckline, or breaks through the resistance line. You can place a stop-loss order (trade stop at a set point) just below the low point of the right shoulder. The take profit level is calculated by measuring the distance between the head and the neckline of the pattern, and then placing the target the same distance from the neckline in the direction of the breakout.
NASDAQ:VXRTLong
by lauralea
1